RadNet
RDNT | NASDAQ
$76.89
+$0.47 (+0.62%)
At close: Nov 16, 2026, 4:00 PM ET
$76.89
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
RadNet Company Profile
Company profile explainedCompany Profile
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Key Executives
| Name | Position |
|---|---|
| Howard G. Berger | Chairman, President & Chief Executive Officer |
| Norman R. Hames | President & CEO of Western Operations |
| Stephen Forthuber | President & CEO of Eastern Operations |
| David Jeffrey Katz | Executive Vice President, Chief Legal Officer & Corporate Secretary |
| Mark D. Stolper | Executive Vice President & Chief Financial Officer |
| Susan Hollabaugh | Chief Information Officer |
| A. Gregory Sorensen | Executive VP, Chief Strategy Officer & Director |
| David Manheim | Senior VP & Chief Compliance Officer |
| Michael Murdock | Executive Vice President of Mergers & Acquisitions |
| Mital Patel | Executive VP & COO |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 26, 2026 | 8-K | Current Report |
| Aug 14, 2026 | 8-K | Current Report |
| Aug 14, 2026 | 424B7 | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 10, 2026 | 10-Q | Quarterly Report |
| Aug 10, 2026 | 8-K | Current Report |
| Jun 22, 2026 | 4 | Filing |
| Jun 18, 2026 | 4 | Filing |
| Jun 18, 2026 | 4 | Filing |
| Jun 16, 2026 | 4 | Filing |
RadNet
| Country | United States |
| IPO Date | Jan 3, 1997 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 9,060 |
| CEO | Howard G. Berger |
Contact Details
1508, 1510 and 1516 Cotner Avenue Los Angeles,
California 90025 United States
Stock Details
| Ticker Symbol | RDNT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000790526 |
| CUSIP Number | 750491102 |
| ISIN Number | US7504911022 |
| SIC Code | 8071 |
Recent News
- 3 days ago / zacks.comWhy RadNet (RDNT) is a Top Momentum Stock for the Long-Term
- 4 days ago / seekingalpha.comRadNet's Imaging Growth Can Fund DeepHealth's Hospital Rollout
- 6 days ago / fool.comRadNet: 3 Key Takeaways for Long-Term Investors
- 6 days ago / seekingalpha.comRadNet: A 'Buy' On Sizable Q3 Beat And Value-Generating M&A
- 7 days ago / seekingalpha.comRadNet, Inc. (RDNT) Q3 2026 Earnings Call Transcript
- 7 days ago / marketbeat.comRadNet Q3 Earnings Call Highlights
- 8 days ago / zacks.comRadNet (RDNT) Reports Q3 Earnings: What Key Metrics Have to Say
- 8 days ago / globenewswire.comRadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges
- 12 days ago / zacks.comRadNet (RDNT) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
- 12 days ago / zacks.comRadNet (RDNT) Soars 9.7%: Is Further Upside Left in the Stock?
Add to Watchlist
Select watchlists to add or remove RDNT